SCHEMBL304096

SCHEMBL304096

COc1ccc(-n2ncc3c(N)cccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.53
MAPK14 Q16539 1/20 0.49
ADORA3 P0DMS8 3/20 0.47
ADORA2A P29274 2/20 0.47
ADORA1 P30542 2/20 0.47
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
HIF1A Q16665 1/20 0.44
NR3C1 P04150 1/20 0.44
SMN1; SMN2 Q16637 7/20 0.43
MAPT P10636 5/20 0.43
RAB9A P51151 4/20 0.43
HTT P42858 3/20 0.43
NPC1 O15118 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 3/20 0.43
S1PR4 O95977 1/20 0.43
S1PR1 P21453 1/20 0.43
PAX8 Q06710 1/20 0.43
LMNA P02545 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30491699 1.00 XDH (0.53) XDHMAPK14ADORA3ADORA2AADORA1
SCHEMBL303982 0.81 CYP17A1 (0.56) MAPK14MKNK1MKNK2NR3C1KMT2A
SCHEMBL476793 0.81 CYP1A2 (0.51) MAPK14MKNK1MKNK2MAPTRAB9A
Hydrochloric Acid SCHEMBL304059 0.80 CYP1A2 (0.50) MAPK14ADORA2AMKNK1MKNK2MAPT
SCHEMBL305462 0.78 CYP1A2 (0.49) MAPK14MKNK1MKNK2MAPTALDH1A1
Hydrochloric Acid SCHEMBL5551165 0.77 MKNK1 (0.42) XDHMKNK1MKNK2NR3C1CYP17A1
SCHEMBL25257558 0.77 XDH (0.53) XDHMKNK1MKNK2HIF1ANR3C1
SCHEMBL30491768 0.77 XDH (0.53) XDHMKNK1MKNK2HIF1ANR3C1
SCHEMBL3289718 0.76 CNR1 (0.50) SMN1; SMN2MAPTALDH1A1LMNAHPGD
SCHEMBL29398584 0.75 HIF1A (0.51) XDHMAPK14ADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059172-A1 INDAZOLE COMPOUND AND PHARMACEUTICAL NIPPON SHINYAKU CO., LTD. (JP) 2025-02-20 US disclosed
EP-4458810-A1 INDAZOLE COMPOUND AND PHARMACEUTICAL Nippon Shinyaku Co., Ltd. (JP) 2024-11-06 EP disclosed
WO-2023127883-A1 INDAZOLE COMPOUND AND PHARMACEUTICAL 日本新薬株式会社 2023-07-06 WO disclosed
EP-1869003-B1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS GLAXO GROUP LTD (GB) 2013-05-15 EP disclosed
US-8093281-B2 Indazoles as glucocorticoid receptor ligands GLAXO GROUP LIMITED (GB) 2012-01-10 US disclosed
US-8093281-B2 Indazoles as glucocorticoid receptor ligands GLAXO GROUP LIMITED (GB) 2012-01-10 US disclosed
US-8093281-B2 Indazoles as glucocorticoid receptor ligands GLAXO GROUP LIMITED (GB) 2012-01-10 US disclosed
US-20090074675-A1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2009-03-19 US disclosed
US-20090074675-A1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2009-03-19 US disclosed
US-20090074675-A1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2009-03-19 US disclosed
EP-1869003-A1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2007-12-26 EP disclosed
WO-2006108699-A1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2006-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250059172-A1 INDAZOLE COMPOUND AND PHARMACEUTICAL MC5R, CYP3A5, PTGIS XDH 972/4885MAPK14 3286/4885ADORA3 754/4885
US-20090074675-A1 INDAZOLES AS GLUCOCORTICOID RECEPTOR LIGANDS NR3C1, NR3C2, MC2R XDH 554/4885MAPK14 1515/4885ADORA3 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.